Assistance Publique - Hôpitaux de Paris: Multiple Sclerosis trials
The registry lists 23 Multiple Sclerosis studies with Assistance Publique - Hôpitaux de Paris as lead sponsor. 7 are open to participants now and 0 have results posted.
Phase 2 2Phase 3 2No phase 19(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- How to Develop the Highest Possible Leading-edge Interdisciplinary Care Model for People With MS, That Will be Relevant to All Stakeholders and Declinable to Different Local Contexts With the Ultimate Goal of Ensuring the Highest Level of Quality of Care in MS.RecruitingNCT07289724
- Ifenprodil as a ReMyelinating repurpOsed Drug in Multiple SclerosisNot yet recruitingNCT06330077Phase 2
- Study of Neuroinflammation in Multiple Sclerosis by PET-MRI Imaging Using the Radiotracer ([18F]-DPA-714) : a Multicentre Cohort Study (INFLANET)RecruitingNCT06280742Not applicable
- Clinical and Urodynamic Assessment of Bladder Sensation in Multiple SclerosisRecruitingNCT05772637Not applicable
- Multimodal Imaging Signatures of the Biological Mechanisms Underlying Neurodegeneration in Multiple SclerosisRecruitingNCT05633875
- Remyelination in Multiple Sclerosis: a PET-MR Longitudinal Study Investigating Individual Profiles of Myelin Repair and the Contribution of NeuroinflammationRecruitingNCT05147532Not applicable
- Effect of Ocrelizumab on Brain Innate Immune Microglial Cells Activation in MS Using PET-MRI With 18F-DPA714RecruitingNCT03691077Phase 3
- MS Fatigue and tDCS on Fatigue in Multiple SclerosisCompletedNCT05890885Not applicable
- In Vitro Effect Study of Interleukin-2 Muteins on Regulatory T Cells of Patients With Different Autoimmune, Allo-immune or Inflammatory DiseasesCompletedNCT05544448Not applicable
- Study of Empathy in MSCompletedNCT05332951
- Impact of the Modifications of Environmental Exposures and Health Care Access During COVID-19 Lockdown on Multiple SclerosisCompletedNCT05033782
- Study of the Humoral Response to SARS-CoV-2 Variants and of the Cellular Response After Vaccination Against COVID-19 in Immunocompromised PeopleCompletedNCT04844489Not applicable
- Periodic Leg Movements' Diagnosis in Spinal Cord Injury: Actigraphy as an Alternative for Polysomnography?CompletedNCT04618978Not applicable
- Self-administered Hyperinsufflation Chest on the Risk of Low Respiratory Infection in Patients With Multiple Sclerosis With Sputum Capacity DeficitStatus unknownNCT04563832Not applicable
- Epidemiological Characteristics of COVID-19 in Patients With MS or NMOCompletedNCT04355611
- Early Detection and Paramedical Care of Sexual Difficulties in Nervous System Diseases: Example of Multiple Sclerosis and Brain Tumors (NEUROSEX)Status unknownNCT03154801Not applicable
- Biological Activity and Safety of Low Dose IL2 in Relapsing Remitting Multiple SclerosisCompletedNCT02424396Phase 2
- Physical Capacity and Rehabilitation of Patients With Multiple SclerosisStatus unknownNCT02352194
- Imaging of Intracerebral Inflammation in MSCompletedNCT02305264Not applicable
- A Trial to Compare the Effectiveness of Two Rehabilitation Programs for Multiple Sclerosis PatientsCompletedNCT01871818Not applicable
- Prognosis Value of the Neuronal Damage in Early Multiple SclerosisStatus unknownNCT01651520Not applicable
- Early Cognitive Impairment in Multiple SclerosisCompletedNCT01157728
- Efficacy of 3,4-DAP in Fatigue Associated With Multiple SclerosisCompletedNCT00190268Phase 3